Nomic develops the nELISA platform, a high-throughput proteomics technology that utilizes DNA nanotechnology to enable flexible multiplexing of protein profiling. This platform addresses the limitations of traditional immunoassays by providing rapid, precise quantification of over 200 cytokines, facilitating comprehensive analysis of the immune secretome.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AV+1Founders
Product
Problem
Traditional immunoassays for protein profiling are limited by their low throughput, cross-reactivity issues, and inflexibility in multiplexing, hindering comprehensive analysis of complex biological systems like the immune secretome. Fixed panels and manual workflows restrict the number of proteins that can be analyzed simultaneously, increasing costs and turnaround times.
Solution
Nomic's nELISA platform overcomes these limitations by leveraging DNA nanotechnology to enable high-throughput, flexible multiplexing of protein profiling. The platform allows for rapid and precise quantification of a large number of cytokines, facilitating in-depth analysis of the immune secretome and other complex proteomic landscapes. With the nELISA, researchers can select specific proteins of interest "à la carte," eliminating the constraints of fixed panels and enabling customized assays. The platform's high throughput capabilities and streamlined workflows significantly reduce turnaround times and costs, making comprehensive protein profiling more accessible.
Target Audience
The primary users are researchers and drug discovery companies in need of high-throughput, flexible, and quantitative protein profiling for applications such as immunology, oncology, and drug development.
Features
- DNA nanotechnology-based ELISA for high-throughput protein profiling
- Flexible multiplexing enabling customized protein panels
- Quantitative profiling with <5% CV day-to-day
- Throughput of 10,000+ samples per week per workcell
- Comprehensive profiling of the immune secretome with ~200 cytokines onboarded
- Multimodal capabilities for studying protein expression, interaction, or modification
- Streamlined service with turnaround times as fast as 1 week